top of page

Abstract Submission Guidelines

Click here for downloadable version

​

If you do not already have an Oxford Abstracts account, you will need to register as a new user.

​

Please sign in with your email address and password if you already have an account.

​

All abstract submissions are not to exceed 250 words.

​

Please note that if your abstract submission is successful, the presenting author is required to register for at least one day of the ACRA 2024 ASM.

​

​

​

​

Categories

   1. Research Abstract

Scientific research in the field of cardiovascular care with original data (including quantitative or qualitative studies) or review papers (systematic reviews, meta-analyses, other review types).

​

Suggested Headings:

  • Background: Outline the knowledge gap. Why is this topic important? State the aim of the research.

  • Methods: Succinctly describe the study design and methodology including the Population/problem; Intervention/Exposure; Comparison/control (if applicable); and Outcome measure. What data were collected and how these were analysed/managed?

  • Results: What were the main findings? Concisely present the analysed data and any table or figure.

  • Conclusions/Implications: What can be concluded from the project? Keep the conclusions verifiable through the findings of the study. State the health/economic/policy implications of the study and considerations for future work.

​

​​

   2. Clinical Abstract

A clinical or quality improvement project that investigates an identified gap in clinical practice, tips for implementation of a new service model, or presentation of challenging clinical scenarios that promote discussion for potential improvements.

​

Suggested Headings:

  • Background/Rationale: Indicate why the topic is important (knowledge gap). Why was the project undertaken?

  • Methods: Succinctly describe what was done and how, by whom, involving whom and where? What measurements/data were taken and how?

  • Outcomes: What were the main findings/discoveries/learnings? Concisely present the analysed data

  • Implications for practice: What are the clinical implications of this work? What can other clinicians learn? How might learnings from this project change practice?

  • Conclusions / Key messages: What can be concluded from the project? Keep the conclusions verifiable through the findings of the study. State the health/economic/policy implications of the study and considerations for future work.

​

​

   3. Clinical Excellence Showcase

Have you implemented an innovative practice or quality improvement project? Overcome a clinical challenge? Set-up a program or service which offers something a little out of the ordinary? These light-hearted presentations are designed to share ideas to improve cardiovascular care in a short, sharp, informative and fun way! We hope to leave delegates with at least one good, practical idea to implement in their own practice.

​

Suggested Content: (These abstracts do not require structured headings)

  • What was the problem you were faced with or gap you needed to fill?

  • How did you go about it? What did you do? What steps did you take?

  • What outcomes have occurred as a result of your innovation/project?

  • Lessons learnt from the process that you can share with others

  • What didn’t work – we are interested to hear about this too!

​

​

Presentation Formats

  • Prize session: The four highest-scoring abstracts per category (research and clinical) will be chosen to present in a prize session. Each presenter will be allocated 10 minutes presentation time, plus 5 minutes for questions. This session will be judged by a panel of experts.

  • Oral presentation:  Each presenter will be allocated 10 minutes presentation time, plus 2 for questions.

  • Clinical Excellence Showcase: Up to five presenters will be chosen to present in the Clinical Excellence Showcase. Each presenter will be allocated 5 minutes presentation time, plus 2 minutes for questions.

  • Moderated Poster: The highest-scoring posters will be chosen to be presented in a moderated poster session. The presenter will be allocated 3 minutes presentation time, plus 1 minute for questions.

  • Poster: Posters will be displayed for the duration of the conference program. There will be a dedicated informal Poster Session during the conference, during which time the presenter will be required to stand beside their poster. 

 

Review Process

All submissions will undergo blind peer-review by the Scientific Committee and abstract examiners. The Scientific Committee will select abstracts to be part of the final program considering the balance of the program.

​

Abstracts will be marked on the following criteria:

  • Conciseness and clarity of information

  • Quality and appropriateness of study design/intervention

  • Results/scientific merit

  • Clarity of conclusions

  • Impact and significance

  • Innovation

 

Abstract submission closes at 23:59 on 5th April 2024.

 

All abstract submitters will be notified of the outcome of their submission at the end of April 2024.

bottom of page